Find a Doctor

Garrett M. Brodeur, MD

Interim Director, Division of Oncology

Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Adjunct professor, The Wistar Institute

Awards

2006, Top Docs for Kids, (Pediatric Hematology/Oncology), Philadelphia Magazine

2005, Top Docs for Kids, (Pediatric Hematology/Oncology), Philadelphia Magazine

2004, Top Docs for Kids, (Pediatric Hematology/Oncology), Philadelphia Magazine

2001, Fellow, American Association for the Advancement of Science

1997, John Morgan Society at the University of Pennsylvania

1995, Honorary Masters of Arts Degree, University of Pennsylvania

1994, The Audrey E. Evans Endowed Chair in Pediatric Oncology, The Children's Hospital of Philadelphia

1990, Alpha Omega Alpha

1985-1990, Research Career Development Award, National Institutes of Health

1985-1990, John A. and George L. Hartford Foundation Research Fellowship

1984-1985, Basil O'Conner Starter Research Grant, March of Dimes

1982-1985, Junior Faculty Clinical Fellowship, American Cancer Society

1975, St. Louis Pediatric Society Award, Washington Univ. School of Medicine

1975, Richard S. Brookings Research Award for Meritorious Research, Washington University School of Medicine

1971, Magna Cum Laude, St. Louis University

1971, Phi Beta Kappa, St. Louis University

1971, Alpha Sigma Nu, St. Louis University

Editorial and Academic Positions

Editorial positions

Editorial boards

1990-present, Cancer and Metastasis Reviews
1989-present, Genes, Chromosomes and Cancer
1987-present, Medical and Pediatric Oncology
1982-present, Cancer Genetics and Cytogenetics

Academic positions

Pediatric Oncology Tumor Board: Neuroblastoma, August 2005

Cancer Pharmacology Course (PHRM 560), U. Penn, Tyrosine kinases as targets for future therapy, February 2006 

Leadership

Memberships in professional organizations

1980-present, American Society of Hematology
1980-present, American Society of Clinical Oncology
1981-present, American Association for Cancer Research
1983-present, American Society for Microbiology
1983-present, American Association for the Advancement of Science
1983-present, American Society of Pediatric Hematology-Oncology
1985-present, Society for Pediatric Research
1989-present, American Society of Human Genetics
1990-present, American Society for Clinical Investigation
2001-present, Member, Osler Interurban Clinical Club  

National and international scientific committees

1986-present, Scientific Advisory Board, National Cancer Center, New York, NY

1989-1999, Scientific Advisory Board, Quebec Neuroblastoma Screening, Program Project, Montreal, Canada

1991-2000, Scientific Advisory Board, William G. Forbeck Research Foundation, Hilton Head Island, SC

2000-present , Scientific Advisory Board, The Fred Hutchinson Cancer Center, Seattle WA

2006-present , Scientific Advisory Board, Harriet W. Samuelsson Foundation 

Academic and institutional committees

2000-present , Neuroblastoma, Strategy Committee, COG
1997-present , Program Leader of Pediatric Oncology, Univ. of Pennsylvania Cancer Center 

Original Papers

2011

Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, et al. Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study. Cancer Chemother Pharmacol. Epub 2011 Feb 22. Cited in PubMed: PMID 21340605.  Read the abstract

2010

Brodeur GM. Getting into the AKT. J Natl Cancer Inst. 2010 Jun 2;102(11):747-9. 2010 Jun 2;102(11):747-9. Epub 2010 May 12. Cited in PubMed: PMID 20463308. Read the article

Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, et al. Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res. 2009 May 15;15(10):3244-50. Epub 2009 May 5. Cited in PubMed: PMID 19417027.  Read the article

Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer. 2009 May 5;100(9):1471-82. Cited in PubMed: PMID 19401703. Read the article

Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. INRG Task Force. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009 Jan 10;27(2):289-97. Epub 2008 Dec 1. Cited in PubMed: PMID 19047291.  Read the article

« Back to Previous Page
  • Print
  • Share

Contact Us